Operational criteria and factors related to recovery from schizophrenia

International Review of Psychiatry

Volumn 14, Issue 4, 2002, Pages 256-272

  Liberman, Robert Paul ^a   Kopelowicz, Alex ^a   Ventura, Joseph ^a   Gutkind, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ALGORITHM; ARTICLE; CASE REPORT; CHRONIC DISEASE; COGNITION; CONVALESCENCE; EMPLOYMENT; FAMILY; HEALTH CARE ACCESS; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOTHERAPY; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL SUPPORT; SYMPTOMATOLOGY; TARDIVE DYSKINESIA;

EID: 0036854428     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/0954026021000016905     Document Type: Article

References (120)

1. American Psychiatric Association (1980). DSMIII: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition. Washington, DC: American Psychiatric Association.
2. American Psychiatric Association (1994). DSMIV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Association.
3. Anthony, W. (1993). Recovery from mental illness. Psychosocial Rehabilitation Journal, 16, 12-23.
4. Awad, A.G. & Hogan, T.P. (1985). Early treatment events and prediction of response to neuroleptics in schizophrenia. Progress in Neuropsychopharmacology & Biological Psychiatry, 9, 585-588.
5. Ayers, T., Liberman, R.P. & Wallace, C.J. (1984). Subjective response to antipsychotic drugs: Failure to replicate predictions of outcome. Journal of Clinical Psychopharmacology, 4, 89-93.
6. Barrowclough, C. & Tarrier, N. (1998). Social functioning and family interventions. In: K.T. MUESER & N. TARRIER (Eds), Handbook of Social Functioning in Schizophrenia (pp. 327-341). Boston: Allyn & Bacon.
7. Bebbington, P. & Kuipers, L. (1994). The predictive utility of expressed emotion in schizophrenia: An aggregate analysis. Psychological Medicine, 24, 707-718.
8. Bellak, L. (Ed.) (1958). Schizophrenia: A Review of the Syndrome. New York: Logos.
9. Bland, R.C. (1982). Predicting the outcome in schizo phrenia. Canadian Journal of Psychiatry, 27, 52-62.
10. Bleuler, E. (1950). Dementia Praecox or the Group of Schizophrenias. Translated and edited by J. Zinkin. New York: International University Press.
11. Bleuler, M. (1968). A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. In: D. Rosenthal & S.S. Kety (Eds), Thetransmission of Schizophrenia. Oxford: Pergamon.
12. Bond, G.R., Becker, D.R., Drake, R.E., Rapp, C.A., Meisler, N., Lehman, A.F., Bell, M.D. & Blyler, C.R. (2001). Implementing supported employment as an evidence-based practice. Psychiatric Services, 52, 313-322.
13. Bowers, M.B., Mazure, C.M., Nelson, J.C. & Jatlow, P.I. (1990). Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin, 16, 81-85.
14. Buchanan, R.W. & GOLD, J.M. (1996). Negative symptoms: Diagnosis, treatment and prognosis. International Clinical Psychopharmacology, (Suppl 2), 3-11.
15. Butzlaff, R.L. & Hooley, J.M. (1998). Expressed emotion and psychiatric relapse. Archives of General Psychiatry, 55, 547-552.
16. Chandler, D., Meiser, J., Hu, T., McGowen, M. & Madison, K. (1997). A capitated model for a cross-section of severely mentally ill clients: Employment outcomes. Community Mental Health Journal, 33, 501-516.
17. Ciompi, L. (1980). Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 6, 606-618.
18. Cleghorn, J.M., Kaplan, R.D., Szechtman, B., Szechtman, H., Brown, G.M. & FRANCO, S. (1991). Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry, 52, 26-30.
19. Corrigan, P.W., Liberman, R.P. & ENGEL, J. (1990). From compliance to adherence in psychiatric treatment: Strategies that facilitate collaboration between practitioners and patient. Hospital and Community Psychiatry, 41, 1203-1211.
20. Crow, T.J., MacMillan, J.E, JOHNSON, A.L. & JOHNSTONE, E. (1986). The Northwick Park study of first episodes of schizophrenia: II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120-127.
21. Cuffel, B.J. (1994). Violent and destructive behavior among the severely mentally ill in rural areas: Evidence from Arkansas' community mental health system. Community Mental Health Journal, 30, 495-504.
22. Davidson, L. & McGlashan, T.H. (1997). The varied outcomes of schizophrenia. Canadian Journal of Psychiatry, 42, 34-43.
23. Davidson, L. & Strauss, J.S. (1995). Beyond the psychosocial model: Integrating disorder, health and recovery. Psychiatry: Interpersonal and Biological Processes, 58, 44-55.
24. Davis, J.M. (1975). Overview: Maintenance therapy in psychiatry: I. Schizophrenia. American Journal of Psychiatry, 132, 1237-1245.
25. DeSisto, M.J., Harding, C.M., McCormick, R.V., Ashikaga, T. & BROOKS, G.W. (1995a). The Maine and Vermont three-decade studies of serious mental illness. I. Matched comparison of cross-sectional outcome. British Journal of Psychiatry, 167, 331-338.
26. DeSisto, M.J., Harding, C.M., McCormick, R.V., Ashikaga, T. & Brooks, G.W. (1995b). The Maine and Vermont three-decade studies of serious mental illness. II. Longitudinal course comparisons. British Journal of Psychiatry, 167, 338-342.
27. Dingman, C.W. & McGlashan, T.H. (1989). Psychotherapy. In: A.S. Bellack (Ed.), A Clinical Guide for the Treatment of Schizophrenia (pp. 263-282). NewYork: Plenum Press.
28. Dixon, L., McFarlane, W.R., Lefley, H., Lucksted, A., Cohen, M., Falloon, I., Mueser, K., Miklowitz, D., Solomon, P. & Sondheimer, D. (2001). Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatric Services, 52, 903-910.
29. Drake, R.E., Essock, S.M., Shaner, A., Carey, K.B., Minkoff, K., Kola, L., Lynde, D., Osher, F.C., Clark, R.E. & Rickards, L. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52, 469-476.
30. Edwards, J., Maude, D., McGorry, P.D., Harrigan, S.M. & Cocks, J.T. (1998). Prolonged recovery in first-episode psychosis. British Journal of Psychiatry, 172 (Suppl 33), 107-116.
31. Falloon, I.R.H. (1999). Optimal treatment for psychosis in an international, multi-site demonstration project. Psychiatric Services, 50, 615-618.
32. Falloon, I.R.H., Held, T., Cloverdale, J.H., Roncone, R. & Laidlaw, T.M. (1999). Family interventions for schizophrenia: A review of international studies of long-term benefits. Psychiatric Rehabilitation Skills, 3, 268-290.
33. Fenton, W.S. & McGlashan, T.H. (1987). Sustained remission in drug-free schizophrenic patients. American Journal of Psychiatry, 144, 1306-1309.
34. Fenton, W.S. & McGlashan, T.H. (1994). Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. American Journal of Psychiatry, 151, 351-356.
35. Forquer, S. & Knight, E. (2001). Managed care: Recovery enhancer or inhibitor? Psychiatric Services, 52, 25-26.
36. Frank, A.F. & Gunderson, J.G. (1990). The role of the therapeutic alliance in the treatment of schizophrenia: Relationship to course and outcome. Archives of General Psychiatry, 47, 228-236.
37. Frank, E., Prien, R.F., Jarrett, R.B., Keller, M.B., Kupfer, D.J., Lavori, P.W., Rush, A.J. & Weissman, M.M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851-855.
38. Frese, F.J., Stanley, J., Kress, K. & Vogel-Scibilia, S. (2001). Integrating evidence-based practices and the recovery model. Psychiatric Services, 52, 1462-1468.
39. Gitlin, M.J., Nuechterlein, K.H., Subotnik, K.L., Ventura, J., Mintz, J., Fogelson, D.L., Bartzokis, G. & Aravagiri, M. (2001). Clinical outcome following neuroleptic discontinuation in remitted recent-onset schizophrenia patients. American Journal of Psychiatry, 158, 1835-1842.
40. Glynn, S.M. (1998). Psychopathology and social functioning in schizophrenia. In: K.T. Mueser & N. Tarrier (Eds), Psychosocial Functioning in Schizophrenia (pp. 66-78). Boston: Allyn & Bacon.
41. Glynn, S.M., Marder, S.R., Liberman, R.P., Blair, K., Wirshing, W.C., Wirshing, D.A., Ross, D. & Mintz, J. (2002). Supplementing clinic-based skills training with manual-based community support sessions: Effects on social adjustment of patients with schizophrenia. American Journal of Psychiatry, 159, 829-837.
42. Gold, S., Arndt, S., Nopoulos, P., O'Leary, D.S. & Andreasen, N. (1999). Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. American Journal of Psychiatry, 156, 1342-1348.
43. Gold, J.M., Bryant, N.L., Vladar, K. & Buchanan, R.W. (1997). Successful vocational functioning in schizophrenia. Schizophrenia Research, 24, 222.
44. Goldstein, M.J. (1999). Psychosocial treatments for individuals with schizophrenia and related disorders. In: N.E. Miller & K.M. Magruder (Eds), Cost-effectiveness of Psychotherapy: A Guide for Practitioners, Researchers, and Policymakers (pp. 235-247). New York: Oxford University Press.
45. Green, M.F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
46. Gunderson, J.G. (1978). Patient/therapist matching: A research evaluation. American Journal of Psychiatry, 135, 1193-1197.
47. Gunderson, J.G., Frank, A.F., Katz, H.M., Vannicelli, M.L., Frosch, J.P., Knapp, P.H. (1984). Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin, 10, 564-598.
48. Hammer, M.A., Katsanis, J. & Iacono, W.G. (1995). The relationship between negative symptoms and neuropsychological performance. Biological Psychiatry, 37, 828-830.
49. Harding, C.M., Brooks, G.W., Ashikaga, T., Strauss, J.S. & Breier, A. (1987a). The Vermont longitudinal study of persons with severe mental illness: I. Methodology, study sample, and overall status 32 years later. American Journal of Psychiatry, 144, 718-726.
50. Harding, C.M., Brooks, G.W., Ashikaga, T., Strauss, J.S. & Breier, A. (1987b). The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144, 727-735.
51. Harding, C.M., Zubin, J. & Strauss, J.S. (1992). Chronicity in schizophrenia: Revisited. British Journal of Psychiatry, 161 (Suppl 18), 27-37.
52. Hegarty, J.D., Baldessarini, R.J., Tohen, M., Waternaux, C. & Oepen, G. (1994). One hundred years of schizophrenia: A meta-analysis of the outcome literature. American Journal of Psychiatry, 151, 1409-1416.
53. Heinssen, R.K., Liberman, R.P. & Kopelowicz, A. (2000). Psychosocial skills training for schizophrenia: Lessons from the laboratory. Schizophrenia Bulletin, 26, 21-46.
54. Helgason, L. (1990). Twenty years' follow-up of first psychiatric presentation for schizophrenia: What could have been prevented? Acta Psychiatrica Scandinavica, 81, 231-235.
55. Hogarty, G.E., Anderson, C.M., Reiss, D.J., Kornblith, S.J., Greenwald, D.P., Javna, C.D. & Madonia, M.J. (1986). Family psycho-education, social skills training and maintenance chemotherapy in aftercare treatment of schizophrenia. 1. One-year effects of a controlled-study on relapse and expressed emotion. Archives of General Psychiatry, 43, 633-642.
56. Hogarty, G.E., Anderson, C.M., Reiss, D.J., Kornblith, S.J., Greenwald, D.P., Ulrich, R.F. & Carter, M. (1991). Family psycho-education, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: II. Two-year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry, 48, 340-347.
57. Hogarty, G.E., Goldberg, S.C. & Schooler, N. (1974). Drug and sociotherapy in the aftercare of schizophrenia patients. III. Adjustment of non-relapsed patients. Archives of General Psychiatry, 31, 609-618.
58. Hoge, S.K., Appelbaum, P.S., Lawlor, T., Beck, J.C., Litman, R., Greer, A., Gutheil, T.G., & Kaplan, E. (1990). A prospective, multicenter study of patients' refusal of antipsychotic medication. Archives of General Psychiatry, 47, 949-956.
59. Huber, G., Gross, G. & Schuttler, R. (1975). A long-term follow-up study of schizophrenia: Psychiatric course of illness and prognosis. Acta Psychiatrica Scandinavica, 52, 49-57.
60. Johnstone, E.C., MacMillan, J.F., Frith, C.D., Benn, D.K. & Crow, T.J. (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157, 182-189.
61. Klimke, A., Klieser, E., Lehmann, E. & Miele, L. (1993). Initial improvement as a criterion for drug choice in acute schizophrenia. Pharmacopsychiatry, 26, 25-29.
62. Kopala, L.C., Fredrikson, D., Good, K.P. & Honer, W.G. (1996). Symptoms in neuroleptic-naive, first-episode schizophrenia: Response to risperidone. Biological Psychiatry, 39, 296-298.
63. Kopelowicz, A., Corrigan, P., Wallace, C. & Liberman, R.P. (1996). Biopsychosocial rehabilitation. In: A. Tasman, J. Kay & J.A. Lieberman (Eds), Psychiatry (pp. 1513-1534). Philadelphia: W.B. Saunders Company.
64. Kopelowicz, A. & Liberman, R.P. (1999). Biobehavioral treatment and rehabilitation of persons with serious mental illness. In: J.R. Scotti (Ed.), New Directions in Behavioral Interventions: Principles, Models, and Practices (pp. 123-128). Baltimore: Brookes Publishing Company.
65. Kopelowicz, A., Liberman, R.P., Mintz, J. & Zarate, R. (1997). Efficacy of social skills training for deficit versus non-deficit negative symptoms in schizophrenia. American Journal of Psychiatry, 154, 424-425.
66. Kraepelin, E. (1919). Dementia Praecox and Paraphrenia. Translated and edited by RB Barclay. Edinburgh: ES Livingston.
67. Lamb, H.R. (1988). One-to-one relationships with the long-term mentally ill: Issues in training professionals. Community Mental Health Journal, 24, 328-337.
68. Lehman, A.F., Steinwachs, D.M., and Port Co-investigators (1998). Translating research into practice: The schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24, 1-10.
69. Liberman, R.P. (2002). Cognitive remediation in schizophrenia. In: H. Kashima, I.R.H. Falloon, M. Mizuno & M. Asai (Eds), Comprehensive Treatment of Schizophrenia (pp. 254-278). Tokyo: Springer-Verlag.
70. Liberman, R.P., Gutkind, D., Mintz, J., Green, M., Marshall, B.D., Robertson, M.J. & Hayden, J. (in press). Impact of risperidone vs. haloperidol on activities of daily living in treatment refractory schizophrenia. Comprehensive Psychiatry.
71. Liberman, R.P., Hilty, D.M., Drake, R.E. & Tsang, H.W.H. (2001). Requirements for multidisciplinary teamwork in psychiatric rehabilitation. Psychiatric Services, 52, 1331-1342.
72. Liberman, R.P., Vaccaro, J.V. & Corrigan, P.W. (1995). Psychiatric rehabilitation. In: H.I. Kaplan & B.J. Sadock (Eds), Comprehensive Textbook of Psychiatry. Baltimore: Williams & Wilkins.
73. Liberman, R.P., Wallace, C.J., BlackwelL, G., Eckman, T.A., Vaccaro, J.V. & Kuehnel, T.G. (1993). Innovations in skills training for the seriously mentally ill: The UCLA Social & Independent living Skills modules. Innovations and Research, 2, 43-60.
74. Liddle, P.F. & Morris, D.L. (1991). Schizophrenic syndromes and frontal lobe performance. British Journal of Psychiatry, 158, 340-345.
75. Lieberman, J.A. & Fenton, W.S. (2000). Delayed detection of psychosis: Causes, consequences and effect on public health. American Journal of Psychiatry, 157, 1727-1730.
76. Lieberman, J., Jody, D., Geisler, S., Alvir, J., Loebel, A., Szymanski, S., Woerner, M. & Borenstein, M. (1993). Time course and biological correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry, 50, 369-376.
77. Lo, W.H. & Lo, T. (1977). A 10-year follow-up study of Chinese schizophrenics in Hong Kong. British Journal of Psychiatry, 131, 63-66.
78. Loebel, A.D., Lieberman, J.A., Alvir, J.M.J., Mayerhoff, D.I., Geisler, S.H. & Szymanski, S.R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry, 149, 1183-1188.
79. Lyons, J.S. & McGovern, M.P. (1989). Use of mental health services by dually diagnosed patients. Hospital and Community Psychiatry, 40, 1067-1069.
80. Lysaker, P. & Bell, M. (1995). Negative symptoms and vocational impairment in schizophrenia: Repeated measurements of work performance over six months. Acta Psychiatrica Scandinavica, 91, 205-208.
81. Marder, S.R., Wirshing, W.C., Mintz, J. & McKenzie, J. (1996). Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry, 153, 1585-1592.
82. May, P.R., Van Putten, T. & Yale, C. (1980). Predicting outcome of antipsychotic drug treatment from early response. American Journal of Psychiatry, 137, 1088-1089.
83. McGlashan, T.H. (1988). A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophrenia Bulletin, 14, 515-542.
84. McGlashan, T.K. (1996). Early detection and intervention in schizophrenia: Research. Schizophrenia Bulletin, 22, 327-345.
85. McGorry, P.D., Edwards, J., Mihalopoulos, C., Harrigan, S.M., Jackson, H.J. (1996). EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22, 305-326.
86. Mellman, T.A., Miller, A.L., Weissman, E.M., Crismon, M.L., Essock, S.M., Marder, S.R. (2001). Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms. Psychiatric Services, 52, 619-625.
87. Morrison, R.L., Bellack, A.S., Wixted, J.T. & Mueser, K.T. (1990). Positive and negative symptoms in schizophrenia: A cluster-analytic approach. Journal of Nervous and Mental Disease, 178, 377-384.
88. Mueser, K.T. & Bond, G.R. (2000). Psychosocial treatment approaches for schizophrenia. Current Opinion in Psychiatry, 13, 27-35.
89. Narrow, W.E., Rae, D.S., Robins, L.N. & Regier, D.A. (2002). Revised prevalence estimates of mental disorders in the United States. Archives of General Psychiatry, 59, 115-123.
90. Nuechterlein, K.H., Subotnik, K.L., Gitlin, M., Dawson, M.E., Ventura, J., Snyder, K.S., Fogelson, D.L., Shaw, S. & Mintz, J. (1999). Neurocognitive and environmental contributors to work recovery after initial onset of schizophrenia: Answers from path analyses. Schizophrenia Research, 36, 179.
91. Ogawa, K., Miya, M., Watarai, A., Nakazawa, M., Yuasa, S. & Utena, H. (1987). A long-term follow-up study of schizophrenia in Japan with special reference to the course of social adjustment. British Journal of Psychiatry, 151, 758-765.
92. Palmer, B.W., Heaton, S.C. & Jeste, D.V. (1999). Older patients with schizophrenia: Challenges in the coming decades. Psychiatric Services, 50, 1178-1183.
93. Paul, G.L. & Lentz, R.J. (1977). Psychosocial Treatment of Chronic Mental Patients: Milieu Versus Social-learning Programs. Cambridge, Mass.: Harvard University Press.
94. Penn, D.L. & Mueser, K.T. (1996). Research update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry, 153, 607-617.
95. Pogue-Geile, M.F. & Harrow, M. (1987). The longitudinal study of negative symptoms in schizophrenia. In: R.R. Grinker & M. Harrow (Eds), Clinical Research in Schizophrenia: A Multidimensional Approach (pp. 189-199). Springfield: Charles C. Thomas.
96. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L. & Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
97. Robinson, D., Woerner, M.G., Alvir, J.M., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D. & Lieberman, J.A. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247.
98. Scott, J.E. & Dixon, L.B. (1995). Psychological interventions for schizophrenia. Schizophrenia Bulletin, 21, 621-630.
99. Shaner, A., Roberts, L.J., Eckman, T.A., Racenstein, J.M., Tucker, D.E., Tsuang, J.W. & Mintz, J. (1998). Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatric Services, 49, 684-690.
100. Spaniol, L. & Koehler, M. (1994). The Experience of Recovery. Boston: Center for Psychiatric Rehabilitation, Boston University.
101. Stein, L.J. & Santos, L.B. (1998). Assertive Community Treatment of Persons with Severe Mental Illness. New York: Norton.
102. Strauss, M. (1993). Relations of symptoms to cognitive deficits in schizophrenia. Schizophrenia Bulletin, 19, 215-232.
103. Strauss, J.S. & Carpenter, W.T. (1974). The prediction of outcome in schizophrenia: II. Relationships between predictor and outcome variables: A report from the Who International Pilot Study of Schizophrenia. Archives of General Psychiatry, 31, 37-42.
104. Sturm, R., Gresenz, C., Pacula, R. & Wells, K. (2000). Labor force participation by persons with mental illness. Psychiatric Services, 50, 1407.
105. Swanson, J.W., Holzer, C.E., Ganju, V.K. & Jono, R.T. (1990). Violence and psychiatric disorder in the community: Evidence from the Epidemiologic Catchment Area surveys. Hospital and Community Psychiatry, 41, 761-770.
106. Swofford, C.D., Kasckow, J.W., Scheller-Gilkey, G. & Inderbitzin, L.B. (1996). Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research, 20, 145-151.
107. Tsuang, M.T., Simpson, J.C. & Kronfol, Z. (1982). Subtypes of drug abuse with psychosis: Demographic characteristics, clinical features, and family history. Archives of General Psychiatry, 39, 141-147.
108. Van Der Does, A.J., Dingemans, P.M., Linszen, D.H., Nugter, M.A. & Scholte, W.F. (1993). Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia. Psychological Medicine, 23, 745-753.
109. Van Der Gaag, M., Kern, R.S., Van Den Bosch, R.J. & Liberman, R.P. (2002). A controlled trial of cognitive remediation in schizophrenia. Schizophrenia Bulletin 28, 167-176.
110. Ventura, J., Green, M.F., Shaner, A. & Liberman, R.P. (1993). Training and quality assurance in the use of the Expanded Brief Psychiatric Rating Scale: The 'drift busters.' International Journal of Methods in Psychiatric Research, 3, 221-244.
111. Wallace, C.J. & Liberman, R.P. (1985). Social skills training for patients with schizophrenia: A controlled clinical trial. Psychiatry Research, 15, 239-247.
112. Warner, R. (1985). Recovery from Schizophrenia: Psychiatry and Political Economy. London: Routledge & Kegan Paul.
113. Warner, R., Taylor, D., Wright, J., Sloat, A., Springett, G., Arnold, S. & Weinberg, H. (1994). Substance use among the mentally ill: Prevalence, reasons for use and effects on illness. American Journal of Orthopsychiatry, 64, 465-476.
114. Weiden, P., Olfson, M. & Essock, S. (1997). Medication noncompliance in schizophrenia: Effects on mental health service policy. In: B. Blackwell (Ed.), Treatment Compliance and the Therapeutic Alliance (pp. 35-60). New York: Harwood Academic Publishers.
115. Wexler, B.E., Hawkins, K.A., Rounsaville, B., Anderson, M., Sernyak, M.J. & Green, M.F. (1997). Normal neurocognitive performance after extended practice in patients with schizophrenia. Schizophrenia Research, 26, 173-180.
116. Whitehorn, D., Lazier, L. & Kopala, L. (1998). Psychosocial rehabilitation early after the onset of psychosis. Psychiatric Services, 49, 1135-1137.
117. Wolkow, K.E. & Ferguson, H. (2001). Community factors in the development of resiliency. Community Mental Health Journal, 37, 489-498.
118. World Health Organization (1980). International Classification of Impairment, Disabilities, and Handicaps. Geneva: World Health Organization.
119. Wyatt, R.J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17, 325-351.
120. Wykes, T., Reeder, C., Corner, J., Williams, C. & Everitt, B. (1999). The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25, 291-307.